Overview
To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.
Description
Primary Objectives
• To evaluate thyroid nodule volume changes over time in participants undergoing RFA as part of clinical care
Secondary Objectives
- To establish the health-related quality of life among participants undergoing with ultrasound guided RFA.
- To evaluate the sonographic features of thyroid nodules over time following ultrasound guided RFA.
- To assess adverse events rates following ultrasound guided RFA.
Eligibility
Eligibility Criteria
- Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC
- Participant is over 18 years and is either not a surgical candidate or has declined surgery.
- Capable and willing to provide written informed consent
- Participant has one of the following diagnoses:
- Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment,
- Biopsy-proven indeterminate nodules (AUS or follicular neoplasm)
- Papillary thyroid carcinoma (PTC) without metastasis
- Locally recurrent thyroid cancer (< 2 cm).
Exclusion Criteria
- Participants meeting any of the following criteria will be excluded:
- Participants considered unsuitable for RFA by the treating physician